Europe Biopharmaceutical Tubing Market to Grow at a CAGR of 8.6% to reach US$ 1,474.45 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Biopharmaceutical Tubing Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Biopharmaceutical Tubing Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Demand for Minimally Invasive Procedures

5.2 Market Opportunities

5.2.1 Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries

5.3 Future Trends

5.3.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing

5.4 Impact of Drivers and Restraints

6. Europe Biopharmaceutical Tubing Market Regional Analysis

6.1 Europe Biopharmaceutical Tubing Market Overview

6.2 Europe Biopharmaceutical Tubing Market Revenue 2019-2028 (US$ Million)

6.3 Europe Biopharmaceutical Tubing Market Forecast Analysis

7. Europe Biopharmaceutical Tubing Market Analysis – by Type

7.1 Plastic

7.1.1 Overview
7.1.2 Plastic: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Metal

7.2.1 Overview
7.2.2 Metal: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Silicone

7.3.1 Overview
7.3.2 Silicone: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Biopharmaceutical Tubing Market Analysis – by Application

8.1 Pharmaceutical

8.1.1 Overview
8.1.2 Pharmaceutical: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Medical Devices

8.2.1 Overview
8.2.2 Medical Devices: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Research and Development

8.3.1 Overview
8.3.2 Research and Development: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Biopharmaceutical Tubing Market – Europe Analysis

9.1 Europe

9.1.1 Europe Biopharmaceutical Tubing Market Breakdown, by Key Country, 2022 and 2028 (%)
9.1.1.1 Europe Biopharmaceutical Tubing Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 UK: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.1.2 UK: Europe Biopharmaceutical Tubing Market Breakdown, by Application

9.1.1.2 Germany: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Germany: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.2.2 Germany: Europe Biopharmaceutical Tubing Market Breakdown, by Application

9.1.1.3 France: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 France: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.3.2 France: Europe Biopharmaceutical Tubing Market Breakdown, by Application

9.1.1.4 Russia: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Russia: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.4.2 Russia: Europe Biopharmaceutical Tubing Market Breakdown, by Application

9.1.1.5 Italy: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Italy: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.5.2 Italy: Europe Biopharmaceutical Tubing Market Breakdown, by Application

9.1.1.6 Rest of Europe: Europe Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Biopharmaceutical Tubing Market Breakdown, by Type
9.1.1.6.2 Rest of Europe: Europe Biopharmaceutical Tubing Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Biopharmaceutical Tubing Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 W. L. Gore and Associates, Inc.

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Saint-Gobain Sekurit

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Freudenberg Group

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 RAUMEDIC AG

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 TEKNI-PLEX

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 NewAge Industries, Inc

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Optinova

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Zeus Industrial Products, Inc.

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 NORDSON CORPORATION

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 DuPont de Nemours, Inc.

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights